{"id":23220,"date":"2024-08-15T09:32:52","date_gmt":"2024-08-15T13:32:52","guid":{"rendered":"https:\/\/medicarereport.org\/?p=23220"},"modified":"2024-08-15T09:33:08","modified_gmt":"2024-08-15T13:33:08","slug":"while-medicare-drug-price-negotiations-dont-apply-to-private-insurance-3-4-million-people-with-employer-coverage-take-at-least-one-of-the-selected-drugs","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=23220","title":{"rendered":"While Medicare Drug Price Negotiations Don\u2019t Apply to Private Insurance, 3.4 Million People with Employer Coverage Take at Least One of the Selected Drugs"},"content":{"rendered":"\n

(Tammie Smith for The Kaiser Family Foundation published August 14, 2024)<\/p>\n\n\n\n

Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new KFF analysis. Medicare is expected to release the negotiated drug prices, which will go into effect in 2026, by no later than September 1, 2024. Continue reading here…<\/a><\/p>\n\n\n\n

\"\"<\/p>\n\n\n\n

Notice:<\/strong>\u00a0The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"

(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42,21,200,53,15],"tags":[120,1380,385,238,400,65,204],"class_list":["post-23220","post","type-post","status-publish","format-standard","hentry","category-employer-healthcare","category-health-care-finance","category-health-insurance","category-hhs","category-part-dprescription-drugs","tag-employer-health-insurance","tag-health-insuarnce","tag-healthcare-costs","tag-healthcare-finance","tag-medicare-drug-price-negotiation-program","tag-medicare-part-d","tag-private-health-plans"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23220"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23220\/revisions"}],"predecessor-version":[{"id":23222,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23220\/revisions\/23222"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}